Lumida
/ACHC
⌘K
Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

ACHC
$28.36USD-0.60%-0.17 today

MARKET CAP

2.6B

P/E (TTM)

FWD P/E

DAY RANGE

$28 – $29

52W RANGE

$11
$36

AI Summary

Stalk
Sell NowMedium

ACHC is entrenched in a Stage 4 decline with bearish medium-term bias confirmed by the Bearish Pivot Point. Long-term trend remains bullish above the rising 200-day SMA, but recent repair attempts have failed, shifting bias downward. Short-term execution favors selling now into resistance around the 9-/20-day EMA zone as rallies continue to be rejected.

  • Q1 revenue reached $828.8M, up 7.6% YoY driven by acute inpatient care
  • Generated $124M in free cash flow and reduced debt by $113M
  • Medicaid volume fell below expectations, denting revenue growth
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$2.3B$2.6B$2.9B$3.2B$3.3B
YoY %+10.7%+12.8%+12.2%+7.7%+5.0%
P / Sales2.4x2.9x2.4x1.2x0.4x
EV / Sales3.3x3.6x3.2x2.0x1.4x
Gross Profit, Adj.$2.3B$2.6B$2.9B$3.2B$3.3B
YoY %+10.7%+12.8%+12.2%+7.7%+5.0%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit3.3x3.6x3.2x2.0x1.4x
EBITDA, Adj.$503.3M$564.0M$645.4M$671.9M$577.2M
YoY %+9.2%+12.1%+14.4%+4.1%-14.1%
Margin %21.7%21.6%22.0%21.3%17.4%
EV / EBITDA15.0x16.8x14.7x9.4x7.9x
EBIT$396.6M$446.2M$56.8M$475.5M$73.4M
YoY %+9.9%+12.5%-87.3%+737.1%-84.6%
Margin %17.1%17.1%1.9%15.1%2.2%
EV / EBIT19.1x21.2x167.0x13.3x61.9x
Net Income$190.6M$273.1M$-21.7M$255.6M$-1.1B
YoY %+128.4%+43.3%-107.9%+1279.7%-531.4%
Net Margin8.2%10.5%-0.7%8.1%-33.3%
EPS (GAAP)$2.10$2.98-$0.24$2.78-$12.16
YoY %+127.7%+41.9%-108.1%+1258.3%-537.4%